COSMOS(SZ:300856)2025-08-26 11:05Financial Performance - The company reported strong performance in the first half of 2025, with a significant increase in revenue compared to the same period in 2024[13]. - Revenue for the reporting period was ¥721,068,308.56, a decrease of 48.67% compared to ¥1,404,695,117.82 in the same period last year[19]. - Net profit attributable to shareholders was ¥65,296,988.47, down 84.51% from ¥421,489,813.03 year-on-year[19]. - Basic earnings per share decreased to ¥0.1373, down 84.55% from ¥0.8889 in the same period last year[19]. - The company's comprehensive gross margin decreased to 32.05% due to a decline in sunscreen product prices and reduced shipment volumes[34]. - The total operating revenue for the first half of 2025 was ¥721,068,308.56, a decrease of 48.7% compared to ¥1,404,695,117.82 in the first half of 2024[174]. - Net profit for the first half of 2025 was ¥63,081,994.56, a decline of 85.0% from ¥421,223,320.60 in the first half of 2024[175]. - The total comprehensive income for the first half of 2025 was ¥78,994,157.83, a decrease of 81.3% from ¥423,421,211.97 in the first half of 2024[176]. Research and Development - Research and development efforts are being prioritized, particularly in the area of new sunscreen formulations that improve skin protection[12]. - The company holds 204 authorized patents, including 59 invention patents, reflecting its strong research and development capabilities[38]. - Research and development investment decreased by 39.91% to ¥39,021,023.64, attributed to a reduction in employee compensation and material consumption[42]. - The R&D center established by the company is focused on developing new chemical products, with an investment of 6.16 million allocated for ongoing projects[68]. - The company is focusing on the development of high-end sunscreen products, with a projected investment of 2.91 million for research and development[68]. Market Strategy and Expansion - The company is focusing on expanding its market presence through strategic partnerships and potential acquisitions to drive growth[12]. - Future guidance indicates a projected revenue growth of approximately 15% for the second half of 2025, driven by increased demand for innovative products[13]. - The company plans to enhance its digital marketing strategies to better engage with consumers and boost online sales[12]. - The company is actively pursuing market expansion strategies, including potential mergers and acquisitions to enhance its product offerings[68]. - The company plans to launch new product lines in the next quarter, aiming for a market share increase of 9%[68]. Financial Position and Cash Flow - The net cash flow from operating activities was ¥59,675,090.79, reflecting a decline of 89.59% compared to ¥573,293,860.92 in the previous year[19]. - The company's cash and cash equivalents decreased by 317.78% to -¥154,864,642.16, reflecting a significant reduction in cash inflow from operating activities[42]. - The total assets at the end of the reporting period were ¥4,033,708,353.86, a decrease of 5.27% from ¥4,258,154,997.78 at the end of the previous year[19]. - Total current assets decreased from ¥2,064,657,895.12 to ¥1,621,740,378.51, a decline of approximately 21.5%[166]. - Cash and cash equivalents decreased from ¥534,033,998.32 to ¥382,258,855.58, a reduction of about 28.4%[166]. Sustainability and Compliance - The company is committed to sustainability, with new formulations that are environmentally friendly and meet regulatory standards[12]. - The company has established a systematic "raw material +" supply model, enhancing its industry position and competitive advantage through continuous innovation and upgrading of formulation application research[39]. - Environmental compliance remains a priority, with ongoing investments in waste management and pollution control to meet stricter regulations[87]. - The company has committed to low-carbon transformation and has joined the Science Based Targets initiative (SBTi) to support climate commitments[100]. Shareholder and Capital Management - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using reserves[5]. - The company has fully utilized the funds raised from the IPO and has canceled the related special account for the raised funds[63]. - The company has achieved a funding utilization rate of 89.62% for the convertible bonds issued[64]. - The company reported a total of 5,466,818 newly restricted shares due to the 2024 equity distribution plan[138]. - The largest shareholder, Kesi Investment, holds 52.00% of the shares, totaling 247,380,000 shares, with an increase of 70,680,000 shares during the reporting period[140]. Risks and Challenges - The company faces risks from fluctuations in raw material prices, which are critical to maintaining profitability, and has implemented strategies to mitigate these risks[87]. - Export revenue is significantly impacted by exchange rate fluctuations, with a high proportion of sales denominated in USD and EUR, necessitating risk management strategies[88]. - The company is actively monitoring macroeconomic conditions that could impact the personal care industry, which is closely tied to its business performance[87].